SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-151744
Filing Date
2014-04-22
Accepted
2014-04-22 08:07:33
Documents
5
Period of Report
2014-04-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d715285d8k.htm 8-K 17701
2 EX-10.1 d715285dex101.htm EX-10.1 10163
3 EX-10.2 d715285dex102.htm EX-10.2 55935
4 EX-99.1 d715285dex991.htm EX-99.1 8202
5 GRAPHIC g715285g37p65.gif GRAPHIC 3410
  Complete submission text file 0001193125-14-151744.txt   97945
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 14775285
SIC: 2834 Pharmaceutical Preparations